These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15617457)

  • 21. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
    Hannedouche T; Chanard J; Baumelou B;
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
    Sharma A; Baliga V;
    J Indian Med Assoc; 2008 Mar; 106(3):191-4, 196. PubMed ID: 18712142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE; Lins LE; Hermansson K
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
    Vogt L; Navis G; Köster J; Manolis AJ; Reid JL; de Zeeuw D;
    J Hypertens; 2005 Nov; 23(11):2055-61. PubMed ID: 16208149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I).
    Williams B; Gosse P; Lowe L; Harper R;
    J Hypertens; 2006 Jan; 24(1):193-200. PubMed ID: 16331118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S; Edwards C; Jones R;
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension.
    Sharma A; Bagchi A; Kinagi SB; Sharma YK; Baliga VP; Bollmall C
    Clin Ther; 2007 Dec; 29(12):2667-76. PubMed ID: 18201582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study.
    Neutel JM; Mancia G; Black HR; Dahlöf B; Defeo H; Ley L; Vinisko R;
    J Clin Hypertens (Greenwich); 2012 Apr; 14(4):206-15. PubMed ID: 22458741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
    Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
    Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: a pilot study.
    Samra SS; Dongre N; Ballary C; Desai A
    J Indian Med Assoc; 2003 May; 101(5):327-8. PubMed ID: 14575232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
    Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
    Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
    Smith DH; Cramer MJ; Neutel JM; Hettiarachchi R; Koval S
    Blood Press Monit; 2003 Jun; 8(3):111-7. PubMed ID: 12900588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
    Lacourcière Y; Tytus R; O'Keefe D; Lenis J; Orchard R; Martin K
    J Hum Hypertens; 2001 Nov; 15(11):763-70. PubMed ID: 11687919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.